Category: Disclosures

[Disclosure] Hanwha Ocean (042660) – Sales and Supply Contract / 2024-10-02

Posted on By K-STOCK Editor
[Disclosure] Hanwha Ocean (042660) – Sales and Supply Contract / 2024-10-02

Fact Source: Financial Supervisory Service DART 💡 3-Second Summary This filing discloses Hanwha Ocean’s contract win valued at KRW 545.4B to construct one Floating Storage Regasification Unit (FSRU) for an Asian shipowner. 📊 [Key Disclosure Highlights & Summary] 📝 Editor’s Comment (Key Follow-up Checkpoint) 📌 Contract Execution and Monitoring Further Adjustments This filing represents a…

Read More “[Disclosure] Hanwha Ocean (042660) – Sales and Supply Contract / 2024-10-02” »

Disclosures, Shipbuilding

[Disclosure] Hyundai Motor (005380) – Provisional Sales Results (Fair Disclosure) / 2024-10-02

Posted on By K-STOCK Editor
[Disclosure] Hyundai Motor (005380) – Provisional Sales Results (Fair Disclosure) / 2024-10-02

Fact Source: Financial Supervisory Service DART 💡 3-Second Summary Hyundai Motor recorded total global sales of 343,824 units in September 2024 (-3.7% YoY), bringing its cumulative sales from January to September 2024 to 3,075,861 units (-1.6% YoY). 📊 [Key Disclosure Contents & Major Figures Summary] 1. Monthly Sales Performance for September 2024 (Unit: Vehicles, %)…

Read More “[Disclosure] Hyundai Motor (005380) – Provisional Sales Results (Fair Disclosure) / 2024-10-02” »

Disclosures, Automotive

[Disclosure] Celltrion (068270) – Application for Phase 3 Clinical Trial Plan for CT-P13 SC in South Korea (Pediatric Ulcerative Colitis) / 2024-09-30

Posted on By K-STOCK Editor
[Disclosure] Celltrion (068270) – Application for Phase 3 Clinical Trial Plan for CT-P13 SC in South Korea (Pediatric Ulcerative Colitis) / 2024-09-30

Fact Source: Financial Supervisory Service DART 💡 3-Second Summary Celltrion announced that it has submitted an application for a Phase 3 clinical trial plan to the Ministry of Food and Drug Safety (MFDS) of South Korea to evaluate the efficacy and safety of CT-P13 SC in pediatric patients with ulcerative colitis. 📊 [Key Disclosure Details…

Read More “[Disclosure] Celltrion (068270) – Application for Phase 3 Clinical Trial Plan for CT-P13 SC in South Korea (Pediatric Ulcerative Colitis) / 2024-09-30” »

Disclosures, Bio & Healthcare

[Disclosure] SK Square (402340) – Decision on Termination of Trust Contract for Treasury Share Acquisition / 2024-09-30

Posted on By K-STOCK Editor
[Disclosure] SK Square (402340) – Decision on Termination of Trust Contract for Treasury Share Acquisition / 2024-09-30

Fact Source: Financial Supervisory Service DART 💡 3-Second Summary SK Square has decided to terminate its KRW 100B treasury share acquisition trust contract due to its expiration and receive the trust assets (cash and 1,271,904 treasury shares) returned to the company. 📊 [Key Disclosure Details & Financial Summary] 📝 Editor’s Comment (Key Follow-up Checkpoint) 📌…

Read More “[Disclosure] SK Square (402340) – Decision on Termination of Trust Contract for Treasury Share Acquisition / 2024-09-30” »

Semiconductors, Disclosures

[Disclosure] SK Square (402340) – Decision on Disposal of Treasury Shares / 2024-09-30

Posted on By K-STOCK Editor
[Disclosure] SK Square (402340) – Decision on Disposal of Treasury Shares / 2024-09-30

Fact Source: Financial Supervisory Service DART 💡 3-Second Summary SK Square has decided to deliver treasury shares following the initial exercise of stock options by an executive, disclosing the full batch of 44,619 shares granted at the same meeting with an initial confirmed disposition of 1,150 shares. 📊 [Key Disclosure Details & Financial Summary] 📝…

Read More “[Disclosure] SK Square (402340) – Decision on Disposal of Treasury Shares / 2024-09-30” »

Semiconductors, Disclosures

[Disclosure] SK Square (402340) – Decision on Disposal of Treasury Shares / 2024-09-30

Posted on By K-STOCK Editor
[Disclosure] SK Square (402340) – Decision on Disposal of Treasury Shares / 2024-09-30

Fact Source: Financial Supervisory Service DART 💡 3-Second Summary SK Square has decided to deliver treasury shares following the initial exercise of stock options by an executive, disclosing the full batch of 237,281 shares from the same shareholders’ meeting with an initial confirmed disposition of 1,350 shares. 📊 [Key Disclosure Details & Financial Summary] 📝…

Read More “[Disclosure] SK Square (402340) – Decision on Disposal of Treasury Shares / 2024-09-30” »

Semiconductors, Disclosures

[Disclosure] Celltrion (068270) – Application for Phase 3 Clinical Trial Plan for CT-P13 SC in South Korea (Pediatric Crohn’s Disease) / 2024-09-30

Posted on By K-STOCK Editor
[Disclosure] Celltrion (068270) – Application for Phase 3 Clinical Trial Plan for CT-P13 SC in South Korea (Pediatric Crohn’s Disease) / 2024-09-30

Fact Source: Financial Supervisory Service DART 💡 3-Second Summary Celltrion announced that it has submitted an application for a Phase 3 clinical trial plan to the Ministry of Food and Drug Safety (MFDS) of South Korea to evaluate the efficacy and safety of CT-P13 SC in pediatric patients with Crohn’s disease. 📊 [Key Disclosure Details…

Read More “[Disclosure] Celltrion (068270) – Application for Phase 3 Clinical Trial Plan for CT-P13 SC in South Korea (Pediatric Crohn’s Disease) / 2024-09-30” »

Disclosures, Bio & Healthcare

[Disclosure] Hanwha Ocean (042660) – Other Management Matters (Voluntary Disclosure) (Correction) / 2024-09-27

Posted on By K-STOCK Editor
[Disclosure] Hanwha Ocean (042660) – Other Management Matters (Voluntary Disclosure) (Correction) / 2024-09-27

Fact Source: Financial Supervisory Service DART 💡 3-Second Summary This filing discloses an amendment to Hanwha Ocean’s business acquisition of the wind power business from Hanwha Corporation, extending the expected acquisition date from October 1, 2024, to December 1, 2024, and modifying settlement timing terms. 📊 [Key Disclosure Highlights & Summary] [Detailed Acquisition Terms] [Other…

Read More “[Disclosure] Hanwha Ocean (042660) – Other Management Matters (Voluntary Disclosure) (Correction) / 2024-09-27” »

Disclosures, Shipbuilding

[Disclosure] Hanwha Ocean (042660) – Decision on Company Merger / 2024-09-27

Posted on By K-STOCK Editor
[Disclosure] Hanwha Ocean (042660) – Decision on Company Merger / 2024-09-27

Fact Source: Financial Supervisory Service DART 💡 3-Second Summary This filing discloses Hanwha Ocean’s decision to absorb its wholly owned subsidiary, Hanwha Ocean Digital Co., Ltd., through a small-scale merger with no new share issuance. 📊 [Key Disclosure Highlights & Summary] [Key Merger Timeline] [Merging Entity (Hanwha Ocean Digital) Overview & Financials (FY2023)] [Other Material…

Read More “[Disclosure] Hanwha Ocean (042660) – Decision on Company Merger / 2024-09-27” »

Disclosures, Shipbuilding

[Disclosure] Hanwha Ocean (042660) – Record Date for Determination of Shareholders / 2024-09-27

Posted on By K-STOCK Editor
[Disclosure] Hanwha Ocean (042660) – Record Date for Determination of Shareholders / 2024-09-27

Fact Source: Financial Supervisory Service DART 💡 3-Second Summary This filing discloses Hanwha Ocean’s setting of October 14, 2024, as the record date to determine eligible shareholders entitled to submit notices of opposition regarding its small-scale merger with Hanwha Ocean Digital Co., Ltd. 📊 [Key Disclosure Highlights & Summary] 📝 Editor’s Comment (Key Follow-up Checkpoint)…

Read More “[Disclosure] Hanwha Ocean (042660) – Record Date for Determination of Shareholders / 2024-09-27” »

Disclosures, Shipbuilding